Neurodegenerative Disease Market Size, Share, Growth Trends and Forecast to 2035
The Neurodegenerative Disease Market is witnessing substantial growth as the prevalence of neurological disorders increases worldwide. According to Market Research Future, the market was valued at USD 68.27 billion in 2024 and is projected to reach USD 152.85 billion by 2035, expanding at a CAGR of 7.6% during the forecast period.
The rising aging population is one of the major factors driving market expansion. Conditions such as Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, amyotrophic lateral sclerosis, and Huntington’s disease are receiving increased attention from healthcare organizations, researchers, and pharmaceutical companies.
Technological advancements are also transforming the market. Artificial intelligence, machine learning, advanced imaging, biomarkers, digital health platforms, and personalized medicine are supporting improvements in disease diagnosis, monitoring, and treatment development. Increasing investment in research and development is further encouraging the discovery of innovative therapies.
North America currently represents a leading regional market, supported by advanced healthcare infrastructure, strong pharmaceutical research capabilities, and substantial investment in neurological research. Asia-Pacific is also expected to experience significant growth because of improving healthcare access and increasing disease awareness.
Overall, increasing disease prevalence, technological innovation, research investments, and demand for effective therapies are expected to create significant opportunities in the global Neurodegenerative Disease Market through 2035.
